BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14751810)

  • 1. Absence of dystrophin in mice reduces NO-dependent vascular function and vascular density: total recovery after a treatment with the aminoglycoside gentamicin.
    Loufrani L; Dubroca C; You D; Li Z; Levy B; Paulin D; Henrion D
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):671-6. PubMed ID: 14751810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defect in microvascular adaptation to chronic changes in blood flow in mice lacking the gene encoding for dystrophin.
    Loufrani L; Levy BI; Henrion D
    Circ Res; 2002 Dec; 91(12):1183-9. PubMed ID: 12480820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilator treatment with hydralazine increases blood flow in mdx mice resistance arteries without vascular wall remodelling or endothelium function improvement.
    Loufrani L; Henrion D
    J Hypertens; 2005 Oct; 23(10):1855-60. PubMed ID: 16148609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin.
    Loufrani L; Matrougui K; Gorny D; Duriez M; Blanc I; Lévy BI; Henrion D
    Circulation; 2001 Feb; 103(6):864-70. PubMed ID: 11171796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide.
    Scotland RS; Chauhan S; Vallance PJ; Ahluwalia A
    Hypertension; 2001 Oct; 38(4):833-9. PubMed ID: 11641295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key role of alpha(1)beta(1)-integrin in the activation of PI3-kinase-Akt by flow (shear stress) in resistance arteries.
    Loufrani L; Retailleau K; Bocquet A; Dumont O; Danker K; Louis H; Lacolley P; Henrion D
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1906-13. PubMed ID: 18245559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.
    Barton-Davis ER; Cordier L; Shoturma DI; Leland SE; Sweeney HL
    J Clin Invest; 1999 Aug; 104(4):375-81. PubMed ID: 10449429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice.
    Chataigneau T; Félétou M; Huang PL; Fishman MC; Duhault J; Vanhoutte PM
    Br J Pharmacol; 1999 Jan; 126(1):219-26. PubMed ID: 10051139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses.
    Dudley RW; Danialou G; Govindaraju K; Lands L; Eidelman DE; Petrof BJ
    Am J Pathol; 2006 Apr; 168(4):1276-87; quiz 1404-5. PubMed ID: 16565501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
    Bexis S; Vandeputte C; McCormick PA; Docherty JR
    Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective microvascular dysfunction in mice lacking the gene encoding for desmin.
    Loufrani L; Matrougui K; Li Z; Levy BI; Lacolley P; Paulin D; Henrion D
    FASEB J; 2002 Jan; 16(1):117-9. PubMed ID: 11729100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial Na
    Ashley Z; Mugloo S; McDonald FJ; Fronius M
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1022-H1032. PubMed ID: 29373035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endothelial nitric oxide in the response to angiotensin II of small mesenteric arteries of the rat.
    Andriantsitohaina R; Okruhlicova L; Côrtes SF; Lagaud GJ; Randriamboavonjy V; Muller B; Stoclet JC
    J Vasc Res; 1996; 33(5):386-94. PubMed ID: 8862144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle.
    Dunant P; Walter MC; Karpati G; Lochmüller H
    Muscle Nerve; 2003 May; 27(5):624-7. PubMed ID: 12707984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
    Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
    Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase.
    Yuen CY; Wong WT; Tian XY; Wong SL; Lau CW; Yu J; Tomlinson B; Yao X; Huang Y
    Cardiovasc Res; 2011 Apr; 90(1):122-9. PubMed ID: 21156825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice.
    Arakawa M; Shiozuka M; Nakayama Y; Hara T; Hamada M; Kondo S; Ikeda D; Takahashi Y; Sawa R; Nonomura Y; Sheykholeslami K; Kondo K; Kaga K; Kitamura T; Suzuki-Miyagoe Y; Takeda S; Matsuda R
    J Biochem; 2003 Nov; 134(5):751-8. PubMed ID: 14688241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hydralazine improves flow (shear stress)-induced endothelium-dependent dilation in mouse mesenteric resistance arteries in vitro.
    Gorny D; Loufrani L; Kubis N; Lévy BI; Henrion D
    Microvasc Res; 2002 Jul; 64(1):127-34. PubMed ID: 12074639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.